Bausch Health Companies | VRX - Cost Of Sales

Stock Price
7.38
Daily Change
0.07 0.96%
Monthly
1.79%
Yearly
4.38%
Q2 Forecast
7.29

Bausch Health Companies reported $1.03B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Amgen USD 1.79B 128M Dec/2025
ANI Pharmaceuticals USD 122.88M 6.86M Dec/2025
Aurora Cannabis CAD 88.61M 30.53M Dec/2025
Bausch Health Companies USD 1.03B 284M Dec/2025
Biogen USD 810.1M 205.1M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Canopy Growth CAD 53.08M 8.3M Dec/2025
Corcept Therapeutics USD 2.54M 2.05M Dec/2025
Danaher USD 2.87B 342M Dec/2025
Drreddys Laboratories INR 40.46B 3.64B Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Gilead Sciences USD 1.62B 50M Dec/2025
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Novo Nordisk DKK 15.15B 2.3B Dec/2025
Pacira USD 54.62M 6.02M Dec/2025
Perrigo USD 747.4M 81.2M Dec/2025
Phibro Animal Health USD 240.42M 2.58M Dec/2025
Prestige Brands USD 131.22M 3.52M Dec/2025
Supernus Pharmaceuticals USD 47.53M 4.24M Dec/2025
Vertex Pharmaceuticals USD 466M 51.2M Dec/2025
Zoetis USD 743M 60M Dec/2025